Catalyst Wire Dossier Catalyst Wire Dossier

IL-YANG Flu Vaccine Quadrivalent Inj

· Il-Yang Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-YANG Flu Vaccine Quadrivalent Inj, covering 2018-09-28 to 2018-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults [Phase 1, Phase 2]

See pricing